The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma - PubMed (original) (raw)

Clinical Trial

The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma

Faruk Tas et al. Med Oncol. 2005.

Abstract

In order to study the relation to the metastatic profile and survival, we evaluated the association between pretreatment serum levels of IL-6, TNF-alpha, and erythropoietin (EPO) and metastatic distribution and survival in 16 patients with metastatic malignant melanoma. IL-6 and TNF-alpha immunoassay (R&D Systems, Inc. Minneapolis, USA) employs the quantitative sandwich enzyme immunoassay technique. The Quantikine IVD EPO ELISA (R&D Systems, Inc.) is based on the double-antibody sandwich method. The baseline serum IL-6 and EPO levels were significantly higher in patients with metastatic malignant melanoma than in the control group (p = 0.009 and p = 0.033, respectively). Serum IL-6 levels were higher in patients with weight loss (p = 0.02), who were anemic (p = 0.026), with elevated serum LDH levels (p = 0.028), and who were chemotherapy nonresponding (p = 0.016). The relationship of serum IL-6 concentration to the tumor burden was not determined. Only serum EPO level was influenced by hemoglobin status (p = 0.001). No difference was shown among these three parameters. Elevated serum IL-6 concentration (p = 0.002) was found to be an adverse prognostic factor in patients with poor performance status, weight loss, low serum hemoglobin, elevated serum LDH, and unresponsive to chemotherapy. On the other hand, both serum TNF-alpha and EPO levels were of no prognostic value. Serum levels of IL-6 were found to be prognostic factors as valuable as serum LDH levels in patients with metastatic malignant melanoma. Their prognostic value should be further evaluated in a larger patient population.

PubMed Disclaimer

Similar articles

• Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
  Tas F, Duranyildiz D, Argon A, Oğuz H, Camlica H, Yasasever V, Topuz E. Tas F, et al. Med Oncol. 2005;22(4):353-8. doi: 10.1385/MO:22:4:353. Med Oncol. 2005. PMID: 16260852
• [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
  Wang W, Zhang MH, Yu Y, Xu CG. Wang W, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):681-4. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399174 Chinese.
• Serum lactate dehydrogenase is a predictor of poor survival in malignant melanoma.
  Gao D, Ma X. Gao D, et al. Panminerva Med. 2017 Dec;59(4):332-337. doi: 10.23736/S0031-0808.16.03216-X. Epub 2016 Jun 16. Panminerva Med. 2017. PMID: 27309261 Review.
• Current position of TNF-α in melanomagenesis.
  Nenu I, Tudor D, Filip AG, Baldea I. Nenu I, et al. Tumour Biol. 2015 Sep;36(9):6589-602. doi: 10.1007/s13277-015-3639-0. Epub 2015 Aug 18. Tumour Biol. 2015. PMID: 26279161 Review.

Cited by

• Interaction of S100A6 Protein with the Four-Helical Cytokines.
  Kazakov AS, Deryusheva EI, Rastrygina VA, Sokolov AS, Permyakova ME, Litus EA, Uversky VN, Permyakov EA, Permyakov SE. Kazakov AS, et al. Biomolecules. 2023 Sep 4;13(9):1345. doi: 10.3390/biom13091345. Biomolecules. 2023. PMID: 37759746 Free PMC article.
• Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop.
  Yi M, Wang W, Chen S, Peng Y, Li J, Cai J, Zhou Y, Peng Q, Ban Y, Zeng Z, Li X, Xiong W, Li G, Xiang B. Yi M, et al. Mol Biol Rep. 2018 Oct;45(5):1277-1287. doi: 10.1007/s11033-018-4288-3. Epub 2018 Aug 3. Mol Biol Rep. 2018. PMID: 30074127
• Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study.
  Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Khojah HM, et al. Clin Rheumatol. 2018 Aug;37(8):2035-2042. doi: 10.1007/s10067-018-4080-8. Epub 2018 Apr 3. Clin Rheumatol. 2018. PMID: 29611086 Clinical Trial.
• Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review).
  Lupu M, Caruntu A, Caruntu C, Papagheorghe LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki M, Drakoulis N, Mamoulakis C, Tzanakakis G, Neagu M, Spandidos DA, Izotov BN, Tsatsakis AM. Lupu M, et al. Oncol Rep. 2017 Sep;38(3):1327-1340. doi: 10.3892/or.2017.5817. Epub 2017 Jul 13. Oncol Rep. 2017. PMID: 28713981 Free PMC article. Review.
• Inhibition of Neoplastic Transformation and Chemically-Induced Skin Hyperplasia in Mice by Traditional Chinese Medicinal Formula Si-Wu-Tang.
  Liu MM, Huang KM, Yeung S, Chang A, Zhang S, Mei N, Parsa C, Orlando R, Huang Y. Liu MM, et al. Nutrients. 2017 Mar 18;9(3):300. doi: 10.3390/nu9030300. Nutrients. 2017. PMID: 28335476 Free PMC article.

References

1. 1. J Clin Oncol. 2000 Nov 15;18(22):3782-93 - PubMed
2. 1. Clin Cancer Res. 1996 Aug;2(8):1405-9 - PubMed
3. 1. Int J Cancer. 2004 Apr 10;109(3):442-8 - PubMed
4. 1. Melanoma Res. 1999 Apr;9(2):181-8 - PubMed
5. 1. Cytokines Cell Mol Ther. 2002;7(4):151-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program